NO20005321D0 - Host-encoded protein expressed in Marek's disease (MDV) infected cells and antibodies thereto - Google Patents

Host-encoded protein expressed in Marek's disease (MDV) infected cells and antibodies thereto

Info

Publication number
NO20005321D0
NO20005321D0 NO20005321A NO20005321A NO20005321D0 NO 20005321 D0 NO20005321 D0 NO 20005321D0 NO 20005321 A NO20005321 A NO 20005321A NO 20005321 A NO20005321 A NO 20005321A NO 20005321 D0 NO20005321 D0 NO 20005321D0
Authority
NO
Norway
Prior art keywords
mdv
marek
antibodies
host
disease
Prior art date
Application number
NO20005321A
Other languages
Norwegian (no)
Other versions
NO20005321L (en
Inventor
Shane Campbell Burgess
Thornton Frederick Davison
Louis Joseph Norman Ross
Original Assignee
Inst Animal Health Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Animal Health Ltd filed Critical Inst Animal Health Ltd
Publication of NO20005321D0 publication Critical patent/NO20005321D0/en
Publication of NO20005321L publication Critical patent/NO20005321L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20005321A 1998-04-29 2000-10-23 Host-encoded protein expressed in Marek's disease (MDV) infected cells and antibodies thereto NO20005321L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9809070.7A GB9809070D0 (en) 1998-04-29 1998-04-29 Biological material and uses thereof
PCT/GB1999/001238 WO1999055860A1 (en) 1998-04-29 1999-04-22 Host-encoded protein expressed on marek's disease (mdv)-infected cells and antibody thereto

Publications (2)

Publication Number Publication Date
NO20005321D0 true NO20005321D0 (en) 2000-10-23
NO20005321L NO20005321L (en) 2000-12-20

Family

ID=10831122

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005321A NO20005321L (en) 1998-04-29 2000-10-23 Host-encoded protein expressed in Marek's disease (MDV) infected cells and antibodies thereto

Country Status (8)

Country Link
EP (1) EP1073735A1 (en)
JP (1) JP2002518995A (en)
CN (1) CN1307638A (en)
AU (1) AU3618099A (en)
CA (1) CA2327178A1 (en)
GB (1) GB9809070D0 (en)
NO (1) NO20005321L (en)
WO (1) WO1999055860A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107090438B (en) * 2017-05-16 2021-01-01 中国农业科学院哈尔滨兽医研究所 Monoclonal antibody of antiserum I type MDV gI protein, hybridoma cell strain secreting antibody and application of monoclonal antibody
JP7760161B2 (en) * 2021-06-08 2025-10-27 国立研究開発法人農業・食品産業技術総合研究機構 Antibodies against Marek's disease virus Meq protein
CN114540312B (en) * 2022-03-16 2023-03-24 河南省农业科学院 A kind of preparation method and application of pp38 monoclonal antibody of serotype 1 Marek's disease virus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11509099A (en) * 1995-07-07 1999-08-17 日本ゼオン株式会社 Marek's disease virus genes and their use in vaccines for protection against Marek's disease

Also Published As

Publication number Publication date
GB9809070D0 (en) 1998-06-24
NO20005321L (en) 2000-12-20
AU3618099A (en) 1999-11-16
WO1999055860A1 (en) 1999-11-04
CA2327178A1 (en) 1999-11-04
EP1073735A1 (en) 2001-02-07
CN1307638A (en) 2001-08-08
WO1999055860A8 (en) 2001-10-04
JP2002518995A (en) 2002-07-02

Similar Documents

Publication Publication Date Title
NO985339D0 (en) Human B cell antigens and related reagents
NO965411D0 (en) N-terminally extended proteins expressed in yeast
NO20000700L (en) Interleukin-18 proteins and their preparation and use
FI964172A7 (en) Gene expression system in vivo
NO983364D0 (en) Consensus Proteins
IS5158A (en) Genetic separators and methods
NO20071415L (en) OB fusion protein preparations and methods
NO20000343L (en) Mammalian cytokine: interleukin-B30 and related reagents
AU3633000A (en) Neutrokine-alpha binding proteins and methods based thereon
NO995928D0 (en) <alpha> -1-antitrypsin preparations and method of preparation thereof
DE69720335D1 (en) Recombinant fructosyl amino acid oxidase
AU2871899A (en) Human receptor proteins; related reagents and methods
AP2001002189A0 (en) Genes and proteins and their uses
NZ314496A (en) Anti fas recombinant antibody protein, dna, vectors, host cells and preparation thereof
ID21034A (en) KINASE PROTEINS AND ITS USE
EP1198468A4 (en) STABILIZED VIRAL ENVELOPE PROTEINS AND USES
EE200200353A (en) Human heparanase-like polypeptide and nucleic acid
NO20005547D0 (en) Myelin-based protein peptides and uses thereof
NO20013101D0 (en) Outer surface proteins, their genes and their use
NO991227D0 (en) PTX-sensitive G proteins, their preparation and use
FR2786773B1 (en) ENVELOPE PROTEINS, METHODS AND USES
EP1142999A4 (en) Novel protein and dna thereof
AU2001291195A1 (en) Nucleotide and protein sequence of helios 3 and methods of use
PL351499A1 (en) Expression of heparin-binding protein in recombinant mammalian cells
EP1026245A4 (en) Antigen protein and nucleic acid coding for said protein

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application